Federal regulators have approved the first new drug for Alzheimer’s disease in nearly 20 years, leaving patients waiting to see how insurers will handle the pricey new treatment. Health care experts expect broad coverage of the drug, which was approved Monday. But what that means for patients will […]
WASHINGTON — The coronavirus vaccine inching toward approval in the U.S. is desperately anticipated by weary Americans longing for a path back to normal life. But criminals are waiting, too, ready to use that desperation to their advantage, federal investigators say. Homeland Security investigators are working with Pfizer, Moderna and dozens of other […]
WASHINGTON — The head of the Food and Drug Administration says vaccine developers will be expected to study COVID-19 shots in racial minorities, the elderly, pregnant women and those with other health conditions. FDA Commissioner Stephen Hahn outlined the guidelines for potential vaccines at a Senate hearing on […]
Founder Editor
